Top-Rated StocksTop-RatedPositive News SentimentPositive NewsNYSE:EVH Evolent Health (EVH) Stock Price, News & Analysis $30.51 +0.16 (+0.53%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$30.05▼$31.1050-Day Range$18.40▼$32.9652-Week Range$17.98▼$35.00Volume1.46 million shsAverage Volume1.62 million shsMarket Capitalization$3.55 billionP/E RatioN/ADividend YieldN/APrice Target$40.40 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Evolent Health alerts: Email Address Evolent Health MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside32.4% Upside$40.40 Price TargetShort InterestBearish13.66% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.71Based on 4 Articles This WeekInsider TradingSelling Shares$9.29 M Sold Last QuarterProj. Earnings Growth24.72%From $0.89 to $1.11 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.59 out of 5 starsComputer And Technology Sector236th out of 594 stocksManagement Services Industry3rd out of 5 stocks 4.5 Analyst's Opinion Consensus RatingEvolent Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 12 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageEvolent Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Evolent Health's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted13.66% of the outstanding shares of Evolent Health have been sold short.Short Interest Ratio / Days to CoverEvolent Health has a short interest ratio ("days to cover") of 6.3.Change versus previous monthShort interest in Evolent Health has recently increased by 10.75%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldEvolent Health does not currently pay a dividend.Dividend GrowthEvolent Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EVH. Previous Next 4.3 News and Social Media Coverage News SentimentEvolent Health has a news sentiment score of 1.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Evolent Health this week, compared to 3 articles on an average week.Search Interest11 people have searched for EVH on MarketBeat in the last 30 days. This is an increase of 175% compared to the previous 30 days.MarketBeat Follows3 people have added Evolent Health to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Evolent Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $9,290,385.00 in company stock.Percentage Held by InsidersOnly 1.60% of the stock of Evolent Health is held by insiders.Read more about Evolent Health's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Evolent Health are expected to grow by 24.72% in the coming year, from $0.89 to $1.11 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Evolent Health is -24.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Evolent Health is -24.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEvolent Health has a P/B Ratio of 3.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Evolent Health's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Golden CrestBiden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.>> Get Your FREE Wealth Protection Guide << About Evolent Health Stock (NYSE:EVH)Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.Read More EVH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EVH Stock News HeadlinesAugust 27, 2024 | insidertrades.comInsider Selling: Evolent Health, Inc. (NYSE:EVH) COO Sells 8,861 Shares of StockAugust 29, 2024 | msn.comEvolent Health, Inc. (EVH): One of Oppenheimer's Top Stock Picks For the Next 12 MonthsSeptember 7, 2024 | True Gold Republic (Ad)China Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… . August 29, 2024 | americanbankingnews.comInsider Selling: Evolent Health, Inc. (NYSE:EVH) COO Sells $265,830.00 in StockAugust 29, 2024 | americanbankingnews.comEvolent Health, Inc. (NYSE:EVH) President Sells $731,876.77 in StockAugust 29, 2024 | finance.yahoo.comEvolent Health, Inc. (EVH): One of Oppenheimer’s Top Stock Picks For the Next 12 MonthsAugust 29, 2024 | americanbankingnews.comTruist Financial Reaffirms Buy Rating for Evolent Health (NYSE:EVH)August 28, 2024 | americanbankingnews.comBrokerages Set Evolent Health, Inc. (NYSE:EVH) Price Target at $40.40September 7, 2024 | True Gold Republic (Ad)China Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… . August 28, 2024 | americanbankingnews.comEvolent Health, Inc. (NYSE:EVH) Receives $40.40 Consensus Price Target from AnalystsAugust 28, 2024 | americanbankingnews.comJonathan Weinberg Sells 42,140 Shares of Evolent Health, Inc. (NYSE:EVH) StockAugust 28, 2024 | americanbankingnews.comJohn Paul Johnson Sells 44,693 Shares of Evolent Health, Inc. (NYSE:EVH) StockAugust 28, 2024 | americanbankingnews.comSeth Blackley Sells 187,904 Shares of Evolent Health, Inc. (NYSE:EVH) StockAugust 28, 2024 | americanbankingnews.comEvolent Health (NYSE:EVH) Rating Reiterated by Royal Bank of CanadaAugust 27, 2024 | investing.comEvolent Health CEO sells $5.6m in stock, acquires shares worth $1.6mAugust 27, 2024 | benzinga.comEvolent Health (NYSE:EVH) Stock Quotes, Forecast and News SummaryAugust 26, 2024 | markets.businessinsider.comTruist Financial Sticks to Its Buy Rating for Evolent Health (EVH)August 26, 2024 | msn.comEvolent Health dips on report Elevance dropped out of biddingSee More Headlines Receive EVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2024Today9/07/2024Next Earnings (Estimated)11/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry Management services Sub-IndustryBusiness Services Current SymbolNYSE:EVH CUSIPN/A CIK1628908 Webwww.evolenthealth.com Phone(571) 389-6000Fax571-389-6001Employees4,700Year FoundedN/APrice Target and Rating Average Stock Price Target$40.40 High Stock Price Target$46.00 Low Stock Price Target$31.00 Potential Upside/Downside+32.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)($1.25) Trailing P/E RatioN/A Forward P/E Ratio34.28 P/E GrowthN/ANet Income$-113,040,000.00 Net Margins-3.16% Pretax Margin-4.01% Return on Equity8.47% Return on Assets3.45% Debt Debt-to-Equity Ratio0.57 Current Ratio1.08 Quick Ratio1.08 Sales & Book Value Annual Sales$2.35 billion Price / Sales1.51 Cash Flow$1.70 per share Price / Cash Flow17.91 Book Value$9.06 per share Price / Book3.37Miscellaneous Outstanding Shares116,213,000Free Float114,354,000Market Cap$3.55 billion OptionableOptionable Beta1.54 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Seth Barrie Blackley (Age 45)Co-Founder, CEO & Director Comp: $2MMr. Dan McCarthy (Age 39)CEO of New Century Health & President Comp: $1.4MMr. John Paul Johnson (Age 40)Chief Financial Officer Comp: $1.13MMr. Aammaad Shams (Age 40)Chief Accounting Officer Comp: $341.78kMr. Robert CruzChief Technology OfficerMs. Jessica WhiteChief Information OfficerMr. Seth R. FrankVice President of Investor RelationsMs. Kali BeyahChief People & Brand OfficerDr. John Tam M.D.Chief Strategy OfficerMr. Scott PritchardPresident of Performance SuiteMore ExecutivesKey CompetitorsGrabNASDAQ:GRABZillow GroupNASDAQ:ZZillow GroupNASDAQ:ZGAllegionNYSE:ALLEFTAI AviationNYSE:FTAIView All CompetitorsInsiders & InstitutionsSeth BlackleySold 187,904 sharesTotal: $5.64 M ($30.00/share)Daniel Joseph MccarthySold 23,693 sharesTotal: $731,876.77 ($30.89/share)John Paul JohnsonSold 44,693 sharesTotal: $1.34 M ($30.00/share)Jonathan WeinbergSold 42,140 sharesTotal: $1.31 M ($31.20/share)Emily Ann RaffertySold 8,861 sharesTotal: $265,830.00 ($30.00/share)View All Insider TransactionsView All Institutional Transactions EVH Stock Analysis - Frequently Asked Questions How have EVH shares performed this year? Evolent Health's stock was trading at $33.03 on January 1st, 2024. Since then, EVH stock has decreased by 7.6% and is now trading at $30.51. View the best growth stocks for 2024 here. How were Evolent Health's earnings last quarter? Evolent Health, Inc. (NYSE:EVH) posted its quarterly earnings results on Thursday, August, 8th. The technology company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.09. The company's revenue for the quarter was up 37.9% compared to the same quarter last year. What is Seth Blackley's approval rating as Evolent Health's CEO? 12 employees have rated Evolent Health Chief Executive Officer Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among the company's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. When did Evolent Health IPO? Evolent Health (EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers. Who are Evolent Health's major shareholders? Evolent Health's top institutional shareholders include William Blair Investment Management LLC (4.32%), Engaged Capital LLC (3.54%), Dimensional Fund Advisors LP (2.04%) and Bank of New York Mellon Corp (1.76%). Insiders that own company stock include Frank J Williams, Seth Blackley, Daniel Joseph Mccarthy, John Paul Johnson, Jonathan Weinberg, Emily Ann Rafferty, Diane Holder, Cheryl Scott, Mary Bridget Duffy and Steve Tutewohl. View institutional ownership trends. How do I buy shares of Evolent Health? Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Evolent Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Evolent Health investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET) and Chipotle Mexican Grill (CMG). This page (NYSE:EVH) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolent Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolent Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
